CAI
Clinical Asset Index
by VOS Supply Group
Drugs · acquisition-cost intelligence

Morphine Sulfate

· ingredient morphine· MORPHINE SULFATE 10 mg/mL; MORPHINE SULFATE 2 mg/mL; MORPHINE SULFATE 4 mg/mL; MORPHINE SULFATE 5 mg/mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$2.32
NADAC — pharmacy acquisition cost, not a retail/cash price

Acquisition-cost history

Weekly NADAC per ML — the trend nobody else shows. 7 weeks.

2025-02-192026-05-20

Same-ingredient options by acquisition cost

Other morphine products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.

ProductNADAC / MLvs this
morphine sulfate$0.31703−$2.00
Morphine Sulfate$0.32100−$2.00
Morphine Sulfate ER$0.36102−$1.96
morphine sulfate$0.41377−$1.91
Morphine Sulfate Extended Release$0.64606−$1.67
morphine sulfate$2.86+$0.54350

Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.